• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典遗传性 V30M 转甲状腺素蛋白淀粉样变性患者外周神经的横截面积增大。

Enlarged cross-sectional area in peripheral nerves in Swedish patients with hereditary V30M transthyretin amyloidosis.

机构信息

Department of Surgical and Perioperative Sciences, Umeå University, Umea, Sweden.

Department of Clinical Microbiology, Umeå University, Umea, Sweden.

出版信息

Ann Med. 2023;55(2):2239269. doi: 10.1080/07853890.2023.2239269.

DOI:10.1080/07853890.2023.2239269
PMID:37619249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10453973/
Abstract

INTRODUCTION

In hereditary transthyretin amyloidosis (ATTRv), two different fibrillar forms causing the amyloid deposition, have been identified, displaying substantially cardiac or neuropathic symptoms. Neuropathic symptoms are more frequent in early-onset patients, whereas late-onset patients, besides cardiac symptoms, seem to develop carpal tunnel syndrome, more often. With ultrasonography (US) of peripheral nerves, it is possible to distinguish structural changes, and enlarged cross-sectional area (CSA). The main purpose of this study was, for the first time, to elucidate US of peripheral nerves in Swedish ATTRv patients at an early stage of the disease, and to evaluate possible early enlarged CSA.

MATERIAL AND METHODS

This prospective study included first visit data of 13 patients, aged 30-88 years, of which 11 with late-onset age. All had a positive V30M mutation. Eight men and six women (aged 28-74 years) served as controls.

RESULTS

Significantly enlarged CSA was seen in ATTRv patients for the tibial nerve at the ankle ( .001), the sural nerve ( .001), the peroneal nerve at the popliteal fossa ( .003), and the ulnar nerve at the middle upper arm ( .007).

CONCLUSION

US of peripheral nerves could be a valuable tool in disease evaluation and could facilitate monitoring of disease progression.

摘要

简介

遗传性转甲状腺素淀粉样变性(ATTRv)中,已经鉴定出两种不同的纤维形式导致淀粉样沉积,表现出明显的心脏或神经病变症状。神经病变症状在早发患者中更为常见,而晚发患者除了心脏症状外,似乎更常发生腕管综合征。通过周围神经超声(US)可以区分结构变化和横截面积(CSA)的增大。本研究的主要目的是首次阐明瑞典 ATTRv 患者在疾病早期的周围神经 US,并评估可能的早期 CSA 增大。

材料和方法

这项前瞻性研究纳入了 13 名年龄在 30-88 岁的患者的首次就诊数据,其中 11 名患者为晚发年龄。所有患者均携带 V30M 突变阳性。8 名男性和 6 名女性(年龄 28-74 岁)作为对照组。

结果

与对照组相比,ATTRv 患者的踝部胫神经( .001)、腓肠神经( .001)、腘窝处腓总神经( .003)和中上臂处尺神经( .007)的 CSA 明显增大。

结论

周围神经超声可能是疾病评估的一种有价值的工具,并有助于监测疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef73/10453973/497b9b05b4c0/IANN_A_2239269_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef73/10453973/badba74c6c6d/IANN_A_2239269_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef73/10453973/8d528978fad8/IANN_A_2239269_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef73/10453973/6c3829b0466d/IANN_A_2239269_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef73/10453973/497b9b05b4c0/IANN_A_2239269_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef73/10453973/badba74c6c6d/IANN_A_2239269_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef73/10453973/8d528978fad8/IANN_A_2239269_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef73/10453973/6c3829b0466d/IANN_A_2239269_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef73/10453973/497b9b05b4c0/IANN_A_2239269_F0004_C.jpg

相似文献

1
Enlarged cross-sectional area in peripheral nerves in Swedish patients with hereditary V30M transthyretin amyloidosis.瑞典遗传性 V30M 转甲状腺素蛋白淀粉样变性患者外周神经的横截面积增大。
Ann Med. 2023;55(2):2239269. doi: 10.1080/07853890.2023.2239269.
2
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP.迟发性遗传性转甲状腺素蛋白淀粉样变多发性神经病患者周围神经的高分辨率超声检查:与慢性炎症性脱髓鞘性多发性神经病的异同
Neurol Sci. 2022 May;43(5):3387-3394. doi: 10.1007/s10072-021-05749-3. Epub 2021 Nov 21.
3
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers.遗传性转甲状腺素蛋白淀粉样变性的神经超声:危险信号和可能的进展生物标志物。
J Neurol. 2021 Jan;268(1):189-198. doi: 10.1007/s00415-020-10127-8. Epub 2020 Aug 4.
4
Peripheral nerve ultrasonography in patients with transthyretin amyloidosis.转甲状腺素蛋白淀粉样变性患者的周围神经超声检查
Clin Neurophysiol. 2017 Apr;128(4):505-511. doi: 10.1016/j.clinph.2017.01.013. Epub 2017 Jan 29.
5
Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.迟发性遗传性转甲状腺素淀粉样变性多发性神经病:THAOS 登记处巴西受试者的特征。
J Neurol Sci. 2019 Aug 15;403:1-6. doi: 10.1016/j.jns.2019.05.030. Epub 2019 May 28.
6
Hereditary Transthyretin Amyloidosis- Clinical and Genetic Characteristics of a Multiracial South-East Asian Cohort in Singapore.遗传性转甲状腺素蛋白淀粉样变性症-新加坡多民族东南亚队列的临床和遗传特征。
J Neuromuscul Dis. 2021;8(4):723-733. doi: 10.3233/JND-210656.
7
Ultrasonographic nerve enlargement in post-transplanted patient with hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性移植后患者的超声神经增粗
Neurol Sci. 2023 May;44(5):1831-1832. doi: 10.1007/s10072-023-06670-7. Epub 2023 Feb 13.
8
Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.磁化传递比定量评估遗传性转甲状腺素蛋白淀粉样变性多发性神经病。
Ann Clin Transl Neurol. 2020 May;7(5):799-807. doi: 10.1002/acn3.51049. Epub 2020 Apr 25.
9
Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M.A97S与V30M型晚发性遗传性转甲状腺素蛋白淀粉样变性中具有相应病理学特征的独特表型
Front Aging Neurosci. 2022 Jan 26;13:786322. doi: 10.3389/fnagi.2021.786322. eCollection 2021.
10
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性中进行性臂丛神经肿大。
J Neurol. 2022 Apr;269(4):1905-1912. doi: 10.1007/s00415-021-10754-9. Epub 2021 Aug 19.

本文引用的文献

1
Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS).转甲状腺素蛋白淀粉样变性心肌病患者自主神经功能障碍特征分析(THAOS)。
Amyloid. 2022 Sep;29(3):175-183. doi: 10.1080/13506129.2022.2043270. Epub 2022 Apr 22.
2
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP.迟发性遗传性转甲状腺素蛋白淀粉样变多发性神经病患者周围神经的高分辨率超声检查:与慢性炎症性脱髓鞘性多发性神经病的异同
Neurol Sci. 2022 May;43(5):3387-3394. doi: 10.1007/s10072-021-05749-3. Epub 2021 Nov 21.
3
The genetics of cardiac amyloidosis.
心脏淀粉样变性的遗传学。
Heart Fail Rev. 2022 Sep;27(5):1485-1492. doi: 10.1007/s10741-021-10164-z. Epub 2021 Sep 13.
4
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性中进行性臂丛神经肿大。
J Neurol. 2022 Apr;269(4):1905-1912. doi: 10.1007/s00415-021-10754-9. Epub 2021 Aug 19.
5
New data on the genetic profile and penetrance of hereditary Val30Met transthyretin amyloidosis in Sweden.瑞典遗传性 Val30Met 转甲状腺素蛋白淀粉样变性的遗传特征和外显率的新数据。
Amyloid. 2021 Jun;28(2):84-90. doi: 10.1080/13506129.2020.1841623. Epub 2020 Nov 4.
6
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy.神经超声检查结果可能成为遗传性转甲状腺素蛋白淀粉样变多发性神经病与慢性炎症性脱髓鞘性多发性神经病鉴别诊断中的陷阱。
Neurol Sci. 2020 Dec;41(12):3775-3778. doi: 10.1007/s10072-020-04717-7. Epub 2020 Sep 16.
7
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers.遗传性转甲状腺素蛋白淀粉样变性的神经超声:危险信号和可能的进展生物标志物。
J Neurol. 2021 Jan;268(1):189-198. doi: 10.1007/s00415-020-10127-8. Epub 2020 Aug 4.
8
Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care.遗传性转甲状腺素蛋白淀粉样变性(hATTR)多发性神经病的诊断与治疗:改善患者护理的当前观点
Ther Clin Risk Manag. 2020 Feb 21;16:109-123. doi: 10.2147/TCRM.S219979. eCollection 2020.
9
Hereditary Transthyretin Amyloidosis: Clinical Presentation and Management Updates.遗传性转甲状腺素蛋白淀粉样变性:临床表现与管理进展
J Clin Neuromuscul Dis. 2020 Mar;21(3):144-156. doi: 10.1097/CND.0000000000000270.
10
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis.依洛瑟那可维持或改善遗传性转甲状腺素蛋白淀粉样变性患者的生活质量。
J Neurol. 2020 Apr;267(4):1070-1079. doi: 10.1007/s00415-019-09671-9. Epub 2019 Dec 18.